Extending Rivaroxaban After COVID-19 Hospitalization. Slomski A. JAMA 2022 Feb 2. pii: 2788849. doi: 10.1001/jama.2022.1533.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Slomski A. Extending Rivaroxaban After COVID-19 Hospitalization. JAMA 2022 Feb 2. pii: 2788849. doi: 10.1001/jama.2022.1533.
PMID: 35107564